BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 23, 2003
View Archived Issues
Roche Licenses Rights To IL-15 Preclinical Program From Cardion
Hoffmann-La Roche Inc. could find itself paying up to $90 million or more for a preclinical research program with transplant rejection and rheumatoid arthritis applications. (BioWorld Today)
Read More
House Passes BioShield Bill That Excludes Two Industry Incentives
Read More
Vancomycin Can't Buck All Bugs; Hospitals Call All Hands To Curb Patient Infection, Test New Drug
Read More
Symyx Signs ExxonMobil Deal: $200M For Fuel-Products Work
Read More
Onyx Raises $71M In Public Offering Of 5 Million Shares
Read More
Diversa Acquiring GSK Antifungal Compounds For $8.6M In Equity
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More